MFDS — authorised 31 May 2013
- Marketing authorisation holder: ECLAT PHARMS LLC
- Status: likely_approved
🇰🇷 Bloxiverz in South Korea
MFDS authorised Bloxiverz on 31 May 2013
Marketing authorisation
Bloxiverz in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Neuroscience approved in South Korea
Frequently asked questions
Is Bloxiverz approved in South Korea?
Yes. MFDS authorised it on 31 May 2013.
Who is the marketing authorisation holder for Bloxiverz in South Korea?
ECLAT PHARMS LLC holds the South Korean marketing authorisation.